bismuth has been researched along with succimer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gansow, OA; Garmestani, K; Jones, SB; Kozak, RW; Tiffany, LJ | 1 |
| De Wolff, FA; Noach, LA; Slikkerveer, A; Tytgat, GN; Van der Voet, GB | 1 |
| Cabassa, C; Flombaum, CD; Jaggi, JS; Kappel, BJ; McDevitt, MR; Scheinberg, DA; Sgouros, G | 1 |
1 trial(s) available for bismuth and succimer
| Article | Year |
|---|---|
Comparison of enhanced elimination of bismuth in humans after treatment with meso-2,3-dimercaptosuccinic acid and D,L-2,3-dimercaptopropane-1-sulfonic acid.
Topics: Adult; Aged; Analysis of Variance; Antacids; Bismuth; Chelating Agents; Gastritis; Helicobacter Infections; Humans; Middle Aged; Organometallic Compounds; Single-Blind Method; Succimer; Unithiol | 1998 |
2 other study(ies) available for bismuth and succimer
| Article | Year |
|---|---|
Evaluation of dithiol chelating agents as potential adjuvants for anti-IL-2 receptor lead or bismuth alpha radioimmunotherapy.
Topics: Adjuvants, Immunologic; Animals; Bismuth; Cell Division; Cell Survival; Chelating Agents; Female; Flow Cytometry; Indicators and Reagents; Lead; Lead Radioisotopes; Mice; Mice, Nude; Radioimmunotherapy; Radioisotopes; Rats; Receptors, Interleukin-2; Succimer; Sulfhydryl Compounds; Tumor Cells, Cultured; Unithiol | 1996 |
Efforts to control the errant products of a targeted in vivo generator.
Topics: Actinium; Alpha Particles; Animals; Antibodies, Monoclonal; Bismuth; Chelating Agents; Female; Francium; Immunotoxins; Kidney; Lymphoma; Macaca fascicularis; Male; Mice; Mice, Inbred BALB C; Mice, SCID; Radioimmunotherapy; Succimer; Unithiol | 2005 |